Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Revenue (2022 - 2025)

Cardio Diagnostics Holdings' Revenue history spans 4 years, with the latest figure at $2855.0 for Q3 2025.

  • For Q3 2025, Revenue fell 56.61% year-over-year to $2855.0; the TTM value through Sep 2025 reached $15782.0, down 55.78%, while the annual FY2024 figure was $34890.0, 104.45% up from the prior year.
  • Revenue for Q3 2025 was $2855.0 at Cardio Diagnostics Holdings, down from $7475.0 in the prior quarter.
  • Across five years, Revenue topped out at $15928.0 in Q1 2024 and bottomed at $940.0 in Q1 2025.
  • The 4-year median for Revenue is $5310.0 (2023), against an average of $5834.1.
  • The largest annual shift saw Revenue skyrocketed 458.95% in 2023 before it tumbled 94.1% in 2025.
  • A 4-year view of Revenue shows it stood at $950.0 in 2022, then surged by 458.95% to $5310.0 in 2023, then dropped by 15.03% to $4512.0 in 2024, then crashed by 36.72% to $2855.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Revenue are $2855.0 (Q3 2025), $7475.0 (Q2 2025), and $940.0 (Q1 2025).